Ketogenic (low-carb + high-fat) diet and remote coaching to “reverse” type 2 diabetes shows 60% of participants had type 2 “reversed," 94% of insulin users reduced or...
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
26 readers recommended
45 readers recommended
As early as 2019, the FDA could approve SGLT-2 inhibitors for adults with type 1, but some patients are already using these pills “off label”; see guidance from leading...
28 readers recommended
Read about combo drug Xultophy, Toujeo vs. Tresiba, diabetes apps, the do-it-yourself community, FreeStyle Libre real-world data, and more!
48 readers recommended
A new trial will test if the once-weekly injectable, Bydureon, is also safe and effective in adolescents.
26 readers recommended
Using time-in-range to assess risk for complications, Omnipod Horizon Closed Loop, Bihormonal closed loop (insulin + Pramlintide), SGLT-2 oral drug for type 1, and more!
123 readers recommended
A review of how far GLP-1 agonists have come – drugs for type 2 diabetes that help with not only blood sugar management, but with weight loss and heart health too
37 readers recommended
Recruiting 1,200 people with type 2 diabetes from diverse ethnic and racial backgrounds for a more thorough understanding of Soliqua’s impact on diabetes management
28 readers recommended
U500 insulin delivery through Omnipod pump, comparing insulin secretion between Mediterranean and ketogenic meals, a head-to-head with Afrezza and NovoLog, Qtern...
42 readers recommended
Admelog will launch this year as the first approved biosimilar rapid-acting insulin. Will it be less expensive than Humalog?
30 readers recommended
Trial shows that a pill version of Ozempic (semaglutide) can lower A1c by as much as 1.5% and also support weight loss
44 readers recommended
A new study is investigating whether higher doses of injectable GLP-1 agonist Trulicity (dulaglutide) are more effective; it is recruiting 1,800 participants with type 2...
62 readers recommended
Farxiga and Sotagliflozin are the first pills to seek approval as add-ons to insulin for type 1; both bring strong time-in-range benefits, and if approved, might launch...
36 readers recommended
The results were so positive it was deemed unethical to keep giving people placebo instead of Invokana, an SGLT-2 inhibitor approved for type 2 diabetes
37 readers recommended
New dose adjustment recommendations for adults and children using Dexcom's G5 CGM based on trend arrows and insulin sensitivity
31 readers recommended
Admelog is Sanofi’s version of Humalog (insulin lispro). New prescription savings card is for both Admelog and Lantus for people who would otherwise need to pay full...
28 readers recommended
The diaTribe Foundation and TCOYD hosted a panel discussion at the ADA 78 th Scientific Sessions in Orlando, Florida; read about insights on how to improve diabetes care
29 readers recommended
A new guidance document from the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) calls for more patient-centered care and...
Possible Breakthrough for Type 2s: The First GLP-1 Pill Is Submitted for Approval to the FDA and EMA
72 readers recommended
The first GLP-1 pill for type 2 diabetes offers weight loss and A1C reduction without injections; US decision expected in September 2019, EU decision expected spring of...
31 readers recommended
FDA updates Invokana label – the type 2 diabetes therapy now improves heart health in type 2’s with established heart disease in addition to glucose lowering
34 readers recommended
If approved, Lilly’s intranasal glucagon would be a radical ease-of-use improvement over current glucagon kits for severe hypoglycemia